MassDevice.com +5 | The top 5 medtech stories for September 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. How medical device risk management is connected with design controls
Medical device design controls play an important role when it comes to risk management, but the relationship isn’t always immediately clear.
Intended use is especially important, says Jon Speer, founder of Greenlight.guru (Indianapolis), which markets a cloud-based quality management software. Read more
4. Bioventus wins FDA nod for Durolane OA joint lubrication product
Bioventus said today it won FDA approval for its Durolane injectable product designed for joint lubrication and treating pain associated with knee osteoarthritis.
Durolane is a single-injection, hyaluornic acid product designed to lubricate joints to treat pain associated with knee osteoarthritis, Durham, N.C.-based Bioventus said. The company acquired it last December from Galderma for an undisclosed amount. Read more
3. Medtronic launches long-term PLF, TLIF Infuse bone protein study
Medtronic said today it launched a long-term clinical study of its Infuse bone graft for use during posterolateral fusion and transforaminal lumba...
Source: Mass Device - Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
More News: Back Pain | Bone Graft | Harvard | Leukemia | Medical Devices | Orthopaedics | Osteoarthritis | Pain | Pain Management | Study